PACB News Alert Pacific Biosciences of California (PACB) 7.46

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Pacific Biosciences of California (PACB) 7.46 $PACB

Uptrend Call Working As Pacific Biosciences of California Stock Rises 28.7% (PACB)
Comtex SmarTrend(R) - Wed Dec 24, 4:58PM CST
SmarTrend identified an Uptrend for Pacific Biosciences of California (NASDAQ ACB) on August 29th, 2014 at $5.80. In approximately 4 months, Pacific Biosciences of California has returned 28.73% as of today's recent price of $7.46.
PACB: 7.46 (+0.01)

5 Crazy Habits You Might Adopt With Low-Cost Genome Sequencing
Maxx Chatsko, The Motley Fool - Motley Fool - Sun Dec 21, 11:42AM CST
The $1,000 human genome took a giant leap closer to reality when Illumina launched the HiSeq X Ten Sequencing System in early 2014. Sequencing your genome costs over five times that amount using any other system, and had cost nearly 10 times...
PACB: 7.46 (+0.01), PFE: 31.42 (-0.03), ILMN: 186.22 (+2.72), PG: 93.14 (-0.15), NVS: 93.91 (+0.66)

How it All Plays Out -- New Research on Pacific Biosciences, Park-Ohio, Perceptron, PGT and Planar Systems
PR Newswire - Fri Dec 19, 7:10AM CST
Moments ago, Analysts Review released new research updates concerning several important developing situations including Pacific Biosciences (NASDAQ: PACB), Park-Ohio (NASDAQ: PKOH), Perceptron (NASDAQ: PRCP), PGT (NASDAQ: PGTI), and Planar Systems (NASDAQ: PLNR). Analysts Review provides a single unified platform for investors' to hear about what matters - proudly employing registered CFA® research staff and rigorous compliance procedures. The full research reports are being made available to the public for informational purposes only.
PACB: 7.46 (+0.01), PGTI: 8.89 (-0.16), PRCP: 10.03 (+0.36), PKOH: 62.28 (-0.51), PLNR: 7.04 (-0.15)

Pacific Biosciences Appoints Kathy Ordonez to Board of Directors
GlobeNewswire - Thu Dec 18, 11:56AM CST
Pacific Biosciences of California, Inc., (Nasdaq ACB) provider of the PacBio RS II Sequencing System, today announced that it has appointed industry veteran Kathy Ordonez to its Board of Directors. Ordonez has a 30 year history of leadership in the life sciences and diagnostics industries, including positions as Senior Vice President of Quest Diagnostics, Chief Executive Officer of Celera, founder of Celera Diagnostics, and President and Chief Executive Officer for Roche Molecular Systems.
PACB: 7.46 (+0.01), DGX: 67.94 (-0.16)

Pacific Biosciences of California Shares Up 17.7% Since SmarTrend's Buy Recommendation (PACB)
Comtex SmarTrend(R) - Wed Dec 17, 11:19AM CST
SmarTrend identified an Uptrend for Pacific Biosciences of California (NASDAQ ACB) on August 29th, 2014 at $5.80. In approximately 4 months, Pacific Biosciences of California has returned 17.69% as of today's recent price of $6.82.
PACB: 7.46 (+0.01)

Shares of PACB Up 16.1% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Mon Dec 08, 10:02AM CST
SmarTrend identified an Uptrend for Pacific Biosciences of California (NASDAQ ACB) on August 29th, 2014 at $5.80. In approximately 3 months, Pacific Biosciences of California has returned 16.13% as of today's recent price of $6.73.
PACB: 7.46 (+0.01)

Uptrend Call Working As Pacific Biosciences of California Stock Rises 16.0% (PACB)
Comtex SmarTrend(R) - Mon Dec 01, 10:04AM CST
SmarTrend identified an Uptrend for Pacific Biosciences of California (NASDAQ ACB) on August 29th, 2014 at $5.80. In approximately 3 months, Pacific Biosciences of California has returned 15.96% as of today's recent price of $6.72.
PACB: 7.46 (+0.01)

Pacific Biosciences Of California (PACB) Flagged As Strong On High Volume
at The Street - Fri Nov 28, 9:11AM CST
Trade-Ideas LLC identified Pacific Biosciences of California (PACB) as a strong on high relative volume candidate
PACB: 7.46 (+0.01)

Global Next Generation Sequencing Technologies Market Analysis - Trends & Forecast to 2020
M2 - Mon Nov 24, 9:56AM CST
Research and Markets (http://www.researchandmarkets.com/research/pnm36r/global_next) has announced the addition of the "Global Next Generation Sequencing Technologies Market Analysis - Trends & Forecast to 2020" report to their offering. The global Next Generation Sequencing market is poised to grow at a CAGR of more than 20% to reach around $5.0 billion by 2020. The NGS market assessment was made based on products, technologies, end users, applications and geography. The NGS products market is further divided into instruments and reagents, services and workflow products. The instruments and consumables is the largest segment with a share of around half of the market in 2013. The fastest growing segment is the services with a highest CAGR during the forecast period. The major players are interested in services segment as it provides additional revenue for the company at the same time, increases the sales of instruments and reagents. NGS technology is segmented into targeted resequencing, whole exome sequencing, RNA sequencing, whole genome sequencing, ChIP sequencing, de novo sequencing and methyl sequencing. Among these targeted re-sequencing technology accounted for the largest share of more than 25% of the technology market in 2013 and is expected to grow at a strong CAGR during the forecast period. Whole genome sequencing is poised to grow at the highest CAGR and expected to reach a share of more than 15% of the total market by 2020. Targeted resequencing and whole genome sequencing technologies are the prospective technologies as various targeted disease based NGS assays and panels are emerging and use of personalized medicine transforms with the understanding of individual's whole genome imprint. Key Topics Covered: 1 Summary 2 Introduction 3 Market Analysis 4 Next Generation Sequencing Market, By Products 5 Global Next Generation Sequencing Market Value And Volume Analysis, By Technology 6 Global Next Generation Sequencing Market, By End Users/Laboratories 7 Global Next Generation Sequencing Market Value And Volume Analysis, By Application 8 Geographic Analysis 9 Competitive Landscape 10 Major Player Profiles - Agilent Technologies, Inc. - Bgi (Beijing Genomics Institute) - Biomatters Ltd - Genomatix Software Gmbh - Hoffmann-La Roche Ltd. - Illumina, Inc. - Pacific Biosciences Of California Inc. - Qiagen N.V. - Strand Life Sciences Pvt. Ltd. - Thermo Fisher Scientific Inc. For more information visit http://www.researchandmarkets.com/research/pn...lobal_next
PACB: 7.46 (+0.01), A: 41.13 (-0.24), ILMN: 186.22 (+2.72), QGEN: 23.20 (+0.09)

Global Next Generation Sequencing (Genome/Exome Sequencing/DNA Sequencing) Market Forecasts and Opportunities, 2020 - Updated Report
M2 - Tue Nov 18, 4:25AM CST
Research and Markets (http://www.researchandmarkets.com/research/h58jql/next_generation) has announced the addition of the "Next Generation Sequencing (Genome/Exome sequencing/DNA sequencing) Global market - Forecast to 2020" report to their offering. Next generation sequencing market is one of the fastest growing segments in the genomics market with an estimated CAGR of around 17.0% in the next five years. The major factors such as rapid adoption of this technology by researchers and its usability as a substitute of microarray technology in addition to its higher throughput, increased accuracy, and affordable costs are driving the next generation sequencing market growth. However, factors such as reducing capital expenditure from academic institutions and huge dependability on grants funding from the government are hampering the next generation sequencing market growth. In addition, the analysis of large amount of data generated by sequencers, and data storage and management is posing a major challenge. The growth opportunities of this market include cloud computing, rising demand for pre-sequencing, developments in NGS fully integrated instruments and rising nanopore sequencing technology. There is a huge opportunity for this technology in the field of drug discovery, personalized medicine, agricultural and animal research. The North American region accounts for the largest share of the next generation sequencing market. The European and Asian markets are also expected to grow due to the favorable funding from the government to adopt this technology. The major factors contributing to this market growth include rising adoption by new customers, rising adoption of high-throughput sequencing platforms by government organizations such as Biotechnology and Biological Sciences Research Council (BBSRC) (U.K.) and NHGRI (National Human Genome Research Institute) (U.S.). Key Topics Covered: 1 Executive Summary 2 Introduction 3 Market Analysis 4 Next Generation Sequencing Market, By Products 5 Next Generation Sequencing Market Value And Volume Analysis, By Technology 6 Next Generation Sequencing Market, By End Users/Laboratories 7 Next Generation Sequencing Market Value And Volume Analysis, By Application Area 8 Geographic Analysis 9 Company Developments 10 Major Player Profiles - Agilent Technologies, Inc. - Beijing Genome Institute - Biomatters, Ltd. - Genomatix Software Gmbh - Illumina Inc. - Life Technologies Corp. - Pacific Biosciences of California Inc. - QIAGEN N.V - Roche Holding Ltd. - Strand Life Sciences Pvt. Ltd. For more information visit http://www.researchandmarkets.com/research/h5...generation
PACB: 7.46 (+0.01), A: 41.13 (-0.24), ILMN: 186.22 (+2.72)

Pacific Biosciences of California Has Returned 17.5% Since SmarTrend Recommendation (PACB)
Comtex SmarTrend(R) - Fri Nov 14, 11:13AM CST
SmarTrend identified an Uptrend for Pacific Biosciences of California (NASDAQ ACB) on August 29th, 2014 at $5.80. In approximately 3 months, Pacific Biosciences of California has returned 17.52% as of today's recent price of $6.81.
PACB: 7.46 (+0.01)

Researchers Use PacBio Sequencing to Create More Complete Human Genome Reference and Discover New Forms of Structural Variation; Paper Published in Nature
GlobeNewswire - Mon Nov 10, 10:02AM CST
Pacific Biosciences of California, Inc., (Nasdaq ACB) provider of the PacBio RS II Sequencing System, announced that a paper published online today in Nature entitled "Resolving the complexity of the human genome using single-molecule sequencing" demonstrates how researchers used Single Molecule, Real-Time (SMRT) Sequencing technology to identify and resolve missing or misassembled regions of the human genome and to access more complex forms of variation not covered by other sequencing technologies.
PACB: 7.46 (+0.01)

Why Pacific Biosciences of California Stock Skyrocketed 34% in October
Sean Williams, The Motley Fool - Motley Fool - Tue Nov 04, 8:39AM CST
PACB data by YCharts What: Shares of Pacific Biosciences of California , a developer of complex machines capable of analyzing human DNA sequences, surged by 34% in October, based on data from S&P Capital IQ , following the company's...
PACB: 7.46 (+0.01)

Big Board Biotech Stocks in Play This Week
ACCESSWIRE - Tue Oct 28, 1:16PM CDT
Coral Gables, FL / ACCESSWIRE / October 28, 2014 / CytRx Corporation (NASDAQ: CYTR) announced that a paper, titled "A Phase 1b/2 Study of Aldoxorubicin in Patients With Soft Tissue Sarcoma," has been published online in Cancer, the prestigious, peer-reviewed journal of the American Cancer Society.
PACB: 7.46 (+0.01), CYTR: 2.58 (+0.03), KERX: 14.00 (+0.20)

New DNA Sequencing Facility Established in China Based on PacBio's SMRT Sequencing Platform
GlobeNewswire - Mon Oct 27, 4:02PM CDT
Pacific Biosciences of California, Inc., (Nasdaq ACB) provider of the PacBio RS II DNA Sequencing System, and Suqian Lakeside Pangu Gene Company (SLPC) announced that SLPC has established a new genomics facility with 1,500 square meters of laboratory space in the Tianjin Dong Li Lake Technology Park, dedicated to using PacBio Single Molecule, Real-Time (SMRT) Sequencing as the major sequencing platform for its translational medicine research projects.
PACB: 7.46 (+0.01)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

CVS Puts Youth Soccer Stories on Its Store Shelves

Updated Category News Views 76

Two kids with real community ties just got a megaphone most grown-ups never receive. CVS Pharmacy has named Caroline, 9, of Holmes Beach, Florida, and Zoe, 12, of Los Angeles, as the first grand-prize winners of its Home Team Heroes youth soccer contest. Each player’s selected nonprofit soccer organization will receive a $25,000 grant, while their stories will appear on...

Continue Reading
Automus and Google Cloud Put Agents to Work on Oracle

Updated Category News Views 96

Oracle back offices are where shiny AI promises go to earn their keep, or get buried under a mountain of integrations. Automus Consulting’s newly announced collaboration with Google Cloud, unveiled November 20 at Oracle AI World, is aimed squarely at that messy middle. The firm wants to combine its Oracle implementation experience with Google Cloud infrastructure and...

Continue Reading
Workers Are Burning Savings as Pay Falls Behind Costs

Updated Category News Views 69

Payroll optimism has been ground into dust by the ordinary bills nobody can dodge. Monster's 2026 Cost of Living Report says 93% of employed U.S. workers feel their wages are failing to keep up with costs, barely different from 95% in both 2024 and 2025. That is not a blip, and it is not workers merely grousing about prices. Three years of nearly identical frustration...

Continue Reading
PayPal's New Leadership Map Puts Execution on Trial

Updated Category News Views 106

Four senior appointments and a risk-chief exit can turn a tidy strategy slide into a very real operating test. PayPal has spent months defining three-year plans, simplifying its operating model and assigning clearer accountability; on November 20, it put names beside the jobs. For NASDAQ:PYPL investors, that is more consequential than another broad promise about...

Continue Reading
SoCalGas Data Program Puts Metering Case Into Focus

Updated Category News Views 61

Buried beneath the usual utility-company polish is a pretty sensible idea: find waste before a customer gets walloped by a bill. SoCalGas says its Advanced Meter Analytics program has helped customers avoid an estimated $11 million in unnecessary natural-gas costs since 2019. That is not a number likely to move Sempra’s earnings by itself, and nobody should pretend...

Continue Reading
YPTC’s Florida Office Bets on Nonprofit Finance Needs

Updated Category News Views 50

A Local Flag Planted After Years of Work Florida nonprofits do not need another consultant waving a glossy slide deck around; they need clean books, grant compliance, and somebody who can tell them where the cash is going before the lights start blinking red. That is the practical opening YPTC is chasing with a Jacksonville-based Florida office, its sixteenth office...

Continue Reading
GreenTree Faces Softer Rooms, Debt and NYSE Deadline

Updated Category News Views 34

A hotel operator can post positive earnings and still leave shareholders with a nasty headache, and GreenTree's third quarter is that kind of report. NYSE:GHG produced RMB243.0 million in revenue, down 22.2% from a year earlier, while net income slipped to RMB49.3 million from RMB59.0 million. This was not a one-line stumble. Room pricing, occupancy, franchise economics...

Continue Reading
Swim Readiness Depends on Skills, Not Birthdays Alone

Updated Category News Views 55

A child popping up calmly after a brief dunk tells you more than a birthday ever will. That is the sensible center of Woody Alpern's guidance for families weighing whether a child belongs in the next swim level. The Atlanta swim school expert's point is refreshingly free of the usual parental race: advancement is earned through repeatable skills, comfort, and judgment in...

Continue Reading
Travel Awards Spotlight Luxury Hospitality's Reach

Updated Category News Views 90

Hong Kong’s awards roll call reads less like a scorecard than a map of where premium travel wants its money and attention to go next. The 2026 World’s Travel & Hotel Awards, released November 20, cast a very wide net: heritage palaces, city hotels, beach retreats, airlines, cruise operators, tourism boards, restaurants, serviced apartments and a fair number of...

Continue Reading
TEN Holdings Raises $1.0 Million as Dilution Looms

Updated Category News Views 66

A Small Raise With a Loud Message Nothing says “we need room to breathe” quite like selling 1,492,500 new shares for $0.67 apiece. TEN Holdings closed a roughly $1.0 million gross equity offering on November 20, 2026, and investors in NASDAQ:XHLD ought to look at this for what it is: a modest cash infusion that comes with immediate dilution. The company gets capital;...

Continue Reading

Top 5 Most Recently Viewed Articles

GoldHaven Resources Expands Exploration Amid Robust Gold Prices

Updated Category News Views 299

Gold's Resilience Fuels Growth Initiatives Gold prices have steadily stabilized above $4,200 per ounce, prompting renewed interest among investors seeking safe-haven assets. This robust price environment encourages extensive drilling programs aimed at expanding resource bases. GoldHaven Resources Corp. (CSE: GOH) is at the forefront of this momentum, actively advancing...

Continue Reading
HSBC Highlights Reliance Industries' Growth Potential and Strategy

Updated Category News Views 287

HSBC Upgrades Reliance Industries Stock Target Recently, HSBC raised its price target for Reliance Industries (RIL:IN) from INR 2,780.00 to INR 3,010.00 while maintaining a Hold rating. This revision reflects a promising outlook on the company's comprehensive business structure and financial standing. Core Sectors Driving Performance HSBC's analysts highlighted Reliance's...

Continue Reading
Vallourec's Strategic Move: Partial Redemption of Notes

Updated Category News Views 142

Vallourec's Strategic Financial Maneuver Vallourec, an industry leader in premium tubular solutions, has made a significant announcement regarding its senior notes due 2032. This decision is part of its ongoing strategy to enhance its financial stability and market position. Details of the Partial Redemption The company plans to redeem $82 million of its senior notes,...

Continue Reading
Health Assurance Foundation Teams Up to Enhance Healthcare Access

Updated Category News Views 80

The Health Assurance Foundation officially launched as a nonprofit back in 2024, focusing on strengthening the healthcare system by investing in local communities. Its mission? Making healthcare more equitable and accessible for everyone. Sounds good on paper, right? But when you peel back the layers, things get murky. Community Health Worker Initiative: Is It Enough? The...

Continue Reading
Market Pay Unveils Seamless POS Solution for Merchants Across Europe

Updated Category News Views 208

Market Pay Launches a Game-Changing Payment Solution The French fintech company Market Pay, a prominent player in the European payment processing field, is excited to unveil its new point-of-sale software payment solution. This innovative app integrates both terminal and smartphone payment options into a single, user-friendly platform. This development not only simplifies...

Continue Reading